News

3 low-beta midcap pharma stocks fall up to 61% in last 1 year

​​Low-beta stocks
iStock
1/4
​​Low-beta stocks
Beta is a measure of the sensitivity of the stock’s price relative to the benchmark index or the overall market. The market beta is 1 and in case the stock has a beta value of 0.3, this implies that the stock is just 30% volatile when compared to the overall market or index.

So, using the StockEdge’s data, here are 4 low beta, low return stocks from the midcap pharma space

GlaxosmithKline Pharmaceuticals
iStock
2/4
GlaxosmithKline Pharmaceuticals

​Beta: 0.03| Last close as on June 21: Rs 1433| Change %: 0.1%| % performance in the last 1 year: -5%
Gland Pharma
iStock
3/4
Gland Pharma

​Beta: 0.08| Last close as on June 21: Rs 1006.35| Change %: -1.5%| % performance in the last 1 year: -61%
IPCA Laboratories
iStock
4/4
IPCA Laboratories
​Beta: 0.27 | Last close as on June 21: Rs 737.25| Change %: 0.8%| % performance in the last 1 year: -18%
Success
This article has been saved